非维生素K依赖口服抗凝药用于CKD合并非瓣膜性房颤:临床实用考量
该综述探讨晚期CKD合并房颤患者使用NOAC的复杂性,因血栓栓塞和出血风险均高于一般人群,需个体化权衡抗凝获益与风险。文章强调准确估算和动态监测肾功能对NOAC选择及剂量调整的重要性,避免剂量不足导致血栓或过量导致出血,并呼吁肾内科医生积极参与多学科团队管理。
要点
- CKD合并房颤患者血栓和出血风险均高,抗凝需个体化评估净临床获益。
- NOAC依赖肾清除,用药前及用药中需准确估算和动态监测肾功能。
- 肾内科医生应作为多学科团队核心成员参与CKD合并房颤患者管理。
核心结论
- NOAC在晚期CKD合并房颤患者中的应用需基于肾功能准确评估和动态监测,个体化权衡血栓与出血风险。
研究设计与样本
- 本文为实用综述,未报告系统检索范围或样本量。
主要发现
- 晚期CKD合并房颤患者血栓栓塞和出血风险均高于一般人群。
- 4种NOAC已作为华法林的补充用于非瓣膜性房颤患者预防系统性血栓栓塞。
- NOAC对肾清除依赖程度不同,剂量不足可致血栓栓塞,药物暴露过量可致出血。
- 已发表文献中存在多个令人担忧的安全性信号。
关键数值与推荐
- 原文未报告具体数值阈值或推荐条款。
临床怎么用
- 使用NOAC前需准确估算肾功能,用药期间动态监测肾功能变化。
- 根据NOAC对肾清除的依赖程度及肾功能调整剂量,避免剂量不足或过量。
- 肾内科医生应积极参与CKD合并房颤患者的多学科团队管理。
局限性
- 本文为实用综述,未报告系统检索策略、纳入研究数量或证据等级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Management of atrial fibrillation (AF) in patients with advanced chronic kidney disease (CKD) poses a complex conundrum because of higher risks for both thromboembolic and bleeding complications compared to the general population. This makes it particularly important for clinicians to carefully weigh the risks versus benefits of anticoagulation therapy to determine the individualized net clinical benefit for every patient. During the past few years, 4 non-vitamin K-dependent oral anticoagulant (NOAC) agents have supplemented warfarin in the therapeutic armamentarium for the prevention of systemic thromboembolism in nonvalvular AF. However, the use of NOACs in CKD specifically mandates a nuanced understanding due to their varying dependence on renal clearance, with resultant safety implications related to either underdosing (thromboembolism) or excessive drug exposure (bleeding). This pragmatic review highlights unique considerations pertaining to accurate estimation and temporal monitoring of kidney function in the context of NOAC use with specific clinical deliberations and variables when determining whether an NOAC is appropriate for a patient with CKD. The dependence of NOACs on renal clearance and several troubling safety signals in the published literature suggest that it is vital for nephrologists to be active members of a multidisciplinary team caring for these high-risk patients with CKD and AF.
引用
- Shroff GR, Stoecker R, Hart A, et al. Non-Vitamin K-Dependent Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With CKD: Pragmatic Considerations for the Clinician. Am J Kidney Dis. 2018. PMID: 29728318. doi:10.1053/j.ajkd.2018.02.360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。